Board of regents commentary qualifications of pharmacists who provide direct patient care: Perspectives on the need for residency training and board certification

Curtis E. Haas, Gary C. Yee, Lawrence J. Cohen, Krystal K. Haase, Bradley G. Phillips, Elizabeth Farrington, Suzanne A. Nesbit, Edith A. Nutescu, Jo E. Rodgers, Terry L. Schwinghammer, Terry L. Seaton, Michael S. Maddux

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

In 2006, the American College of Clinical Pharmacy (ACCP) released a position statement and a white paper to provide the College's viewpoints on the importance of postgraduate pharmacy residency training as a prerequisite for direct patient care practice and the vision that future clinical pharmacists engaged in direct patient care would be certified by the Board of Pharmacy Specialties (BPS). Since the release of these papers, some members of the pharmacy profession have interpreted ACCP's position as maintaining that all pharmacists-regardless of the focus of their professional practice activities-should complete formal postgraduate residency training and be board-certified specialists. That interpretation is not accurate. In this commentary, ACCP further defines "direct patient care" and states that it believes that clinical pharmacists engaged in direct patient care should be board certified (i.e., and residency-trained or otherwise board eligible) and have established a valid collaborative drug therapy management (CDTM) agreement or have been formally granted clinical privileges. The rationale for this viewpoint is presented in detail. The pharmacy profession has appropriately invested substantial resources to ensure the quality of its accredited residency training programs and board certification processes. ACCP believes that these training and certification programs are essential steps in preparing clinical pharmacists to provide direct patient care.

Original languageEnglish
Pages (from-to)888-891
Number of pages4
JournalPharmacotherapy
Volume33
Issue number8
DOIs
StatePublished - 1 Aug 2013

Fingerprint

Certification
Internship and Residency
Pharmacists
Patient Care
Pharmacy Residencies
Specialty Boards
Medication Therapy Management
Education
Professional Practice

Keywords

  • American college of clinical pharmacy
  • Board certification
  • Clinical pharmacist
  • Comprehensive medication management
  • Direct patient care
  • Pharmacists
  • Residency training

Cite this

Haas, Curtis E. ; Yee, Gary C. ; Cohen, Lawrence J. ; Haase, Krystal K. ; Phillips, Bradley G. ; Farrington, Elizabeth ; Nesbit, Suzanne A. ; Nutescu, Edith A. ; Rodgers, Jo E. ; Schwinghammer, Terry L. ; Seaton, Terry L. ; Maddux, Michael S. / Board of regents commentary qualifications of pharmacists who provide direct patient care : Perspectives on the need for residency training and board certification. In: Pharmacotherapy. 2013 ; Vol. 33, No. 8. pp. 888-891.
@article{2271a751259c4867b3a34fd2832bdc82,
title = "Board of regents commentary qualifications of pharmacists who provide direct patient care: Perspectives on the need for residency training and board certification",
abstract = "In 2006, the American College of Clinical Pharmacy (ACCP) released a position statement and a white paper to provide the College's viewpoints on the importance of postgraduate pharmacy residency training as a prerequisite for direct patient care practice and the vision that future clinical pharmacists engaged in direct patient care would be certified by the Board of Pharmacy Specialties (BPS). Since the release of these papers, some members of the pharmacy profession have interpreted ACCP's position as maintaining that all pharmacists-regardless of the focus of their professional practice activities-should complete formal postgraduate residency training and be board-certified specialists. That interpretation is not accurate. In this commentary, ACCP further defines {"}direct patient care{"} and states that it believes that clinical pharmacists engaged in direct patient care should be board certified (i.e., and residency-trained or otherwise board eligible) and have established a valid collaborative drug therapy management (CDTM) agreement or have been formally granted clinical privileges. The rationale for this viewpoint is presented in detail. The pharmacy profession has appropriately invested substantial resources to ensure the quality of its accredited residency training programs and board certification processes. ACCP believes that these training and certification programs are essential steps in preparing clinical pharmacists to provide direct patient care.",
keywords = "American college of clinical pharmacy, Board certification, Clinical pharmacist, Comprehensive medication management, Direct patient care, Pharmacists, Residency training",
author = "Haas, {Curtis E.} and Yee, {Gary C.} and Cohen, {Lawrence J.} and Haase, {Krystal K.} and Phillips, {Bradley G.} and Elizabeth Farrington and Nesbit, {Suzanne A.} and Nutescu, {Edith A.} and Rodgers, {Jo E.} and Schwinghammer, {Terry L.} and Seaton, {Terry L.} and Maddux, {Michael S.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1002/phar.1285",
language = "English",
volume = "33",
pages = "888--891",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Wiley-Blackwell",
number = "8",

}

Haas, CE, Yee, GC, Cohen, LJ, Haase, KK, Phillips, BG, Farrington, E, Nesbit, SA, Nutescu, EA, Rodgers, JE, Schwinghammer, TL, Seaton, TL & Maddux, MS 2013, 'Board of regents commentary qualifications of pharmacists who provide direct patient care: Perspectives on the need for residency training and board certification', Pharmacotherapy, vol. 33, no. 8, pp. 888-891. https://doi.org/10.1002/phar.1285

Board of regents commentary qualifications of pharmacists who provide direct patient care : Perspectives on the need for residency training and board certification. / Haas, Curtis E.; Yee, Gary C.; Cohen, Lawrence J.; Haase, Krystal K.; Phillips, Bradley G.; Farrington, Elizabeth; Nesbit, Suzanne A.; Nutescu, Edith A.; Rodgers, Jo E.; Schwinghammer, Terry L.; Seaton, Terry L.; Maddux, Michael S.

In: Pharmacotherapy, Vol. 33, No. 8, 01.08.2013, p. 888-891.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Board of regents commentary qualifications of pharmacists who provide direct patient care

T2 - Perspectives on the need for residency training and board certification

AU - Haas, Curtis E.

AU - Yee, Gary C.

AU - Cohen, Lawrence J.

AU - Haase, Krystal K.

AU - Phillips, Bradley G.

AU - Farrington, Elizabeth

AU - Nesbit, Suzanne A.

AU - Nutescu, Edith A.

AU - Rodgers, Jo E.

AU - Schwinghammer, Terry L.

AU - Seaton, Terry L.

AU - Maddux, Michael S.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - In 2006, the American College of Clinical Pharmacy (ACCP) released a position statement and a white paper to provide the College's viewpoints on the importance of postgraduate pharmacy residency training as a prerequisite for direct patient care practice and the vision that future clinical pharmacists engaged in direct patient care would be certified by the Board of Pharmacy Specialties (BPS). Since the release of these papers, some members of the pharmacy profession have interpreted ACCP's position as maintaining that all pharmacists-regardless of the focus of their professional practice activities-should complete formal postgraduate residency training and be board-certified specialists. That interpretation is not accurate. In this commentary, ACCP further defines "direct patient care" and states that it believes that clinical pharmacists engaged in direct patient care should be board certified (i.e., and residency-trained or otherwise board eligible) and have established a valid collaborative drug therapy management (CDTM) agreement or have been formally granted clinical privileges. The rationale for this viewpoint is presented in detail. The pharmacy profession has appropriately invested substantial resources to ensure the quality of its accredited residency training programs and board certification processes. ACCP believes that these training and certification programs are essential steps in preparing clinical pharmacists to provide direct patient care.

AB - In 2006, the American College of Clinical Pharmacy (ACCP) released a position statement and a white paper to provide the College's viewpoints on the importance of postgraduate pharmacy residency training as a prerequisite for direct patient care practice and the vision that future clinical pharmacists engaged in direct patient care would be certified by the Board of Pharmacy Specialties (BPS). Since the release of these papers, some members of the pharmacy profession have interpreted ACCP's position as maintaining that all pharmacists-regardless of the focus of their professional practice activities-should complete formal postgraduate residency training and be board-certified specialists. That interpretation is not accurate. In this commentary, ACCP further defines "direct patient care" and states that it believes that clinical pharmacists engaged in direct patient care should be board certified (i.e., and residency-trained or otherwise board eligible) and have established a valid collaborative drug therapy management (CDTM) agreement or have been formally granted clinical privileges. The rationale for this viewpoint is presented in detail. The pharmacy profession has appropriately invested substantial resources to ensure the quality of its accredited residency training programs and board certification processes. ACCP believes that these training and certification programs are essential steps in preparing clinical pharmacists to provide direct patient care.

KW - American college of clinical pharmacy

KW - Board certification

KW - Clinical pharmacist

KW - Comprehensive medication management

KW - Direct patient care

KW - Pharmacists

KW - Residency training

UR - http://www.scopus.com/inward/record.url?scp=84885221742&partnerID=8YFLogxK

U2 - 10.1002/phar.1285

DO - 10.1002/phar.1285

M3 - Review article

C2 - 23625823

AN - SCOPUS:84885221742

VL - 33

SP - 888

EP - 891

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 8

ER -